Article
In vitro and in vivo venom-inhibition assays identify metalloproteinase-inhibiting drugs…
medRxiv · 2022 · Menzies, S. K.; Clare, R. H.; Xie, C.; Westhorpe, A.; Hall, S. R.; Edge, R. J.; Alsolaiss, J.; Crittenden, E.; Harrison, R. A.; Kool, J.; Casewell, N. R.
Key facts
| Title | In vitro and in vivo venom-inhibition assays identify metalloproteinase-inhibiting drugs as potential treatments for snakebite envenoming by Dispholidus typus |
|---|---|
| First author | Menzies, S. K.; Clare, R. H.; Xie, C.; Westhorpe, A.; Hall, S. R.; Edge, R. J.; Alsolaiss, J.; Crittenden, E.; Harrison, R. A.; Kool, J.; Casewell, N. R. |
| Journal | medRxiv |
| Published | Jan 7, 2022 |
| DOI | 10.1101/2022.01.07.475313 |
| Devices mentioned | 204806 |
| Product codes mentioned | KIE |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1